All Stories

  1. Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing
  2. Development of a Genetic Risk Score to predict the risk of overweight and obesity in European adolescents from the HELENA study
  3. Mediterranean Diet, Screen-Time-Based Sedentary Behavior and Their Interaction Effect on Adiposity in European Adolescents: The HELENA Study
  4. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery
  5. Interaction Effect of the Mediterranean Diet and an Obesity Genetic Risk Score on Adiposity and Metabolic Syndrome in Adolescents: The HELENA Study
  6. Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings
  7. A cohort study of fetal growth in twin pregnancies by chorionicity: comparison with European and American standards
  8. Actualización y optimización de la vigilancia activa en cáncer de próstata en 2021
  9. Prediction of Large for Gestational Age by Ultrasound at 35 Weeks and Impact of Ultrasound-Delivery Interval: Comparison of 6 Standards
  10. Mastectomía contralateral profiláctica con reconstrucción inmediata en pacientes con cáncer de mama unilateral sin mutación germinal en BRCA1/2
  11. Validation of a 2‐gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening population
  12. Types of pathological progression within Spanish Register on Active Surveillance and their relevance in radical prostatectomy specimens
  13. Las biopsias de próstata dirigidas ¿están listas para reemplazar las biopsias de próstata sistemáticas?
  14. How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies
  15. Pregestational body mass index, trimester-specific weight gain and total gestational weight gain: how do they influence perinatal outcomes?
  16. Detection of Adverse Perinatal Outcomes at Term Delivery Using Ultrasound Estimated Percentile Weight at 35 Weeks of Gestation: Comparison of Five Fetal Growth Standards
  17. Clinical utility of thrombophilia, anticoagulant treatment, and maternal variables as predictors of placenta-mediated pregnancy complications: an extensive analysis
  18. External validation of SelectMDx (v1) in an opportunistic screening cohort in first TRUS-guided biopsy without MRI imaging
  19. Role of the 4Kscore test as a predictor of reclassification in prostate cancer active surveillance
  20. MP12-19 4KSCORE TEST AS A PREDICTOR OF RECLASSIFICATION IN PROSTATE CANCER ACTIVE SURVEILLANCE
  21. Variabilidad dentro del Registro Nacional multicéntrico en Vigilancia Activa; cuestionario a urólogos
  22. Maternal morbidity after implementation of a postpartum hemorrhage protocol including use of misoprostol
  23. Variability within the national registry of active surveillance in prostate cancer in Spain
  24. The management of active surveillance in prostate cancer: Validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry
  25. Physico-mechanical properties of multi-recycled self-compacting concrete prepared with precast concrete rejects
  26. Comparison of fetal weight distribution improved by paternal height by Spanish standard versus Intergrowth 21st standard
  27. MP43-12 PREDICTING PROGRESSION IN ACTIVE SURVEILLANCE; EXTERNAL VALIDATION OF THE CANARY PASS RISK CALCULATOR WITH THE SPANISH UROLOGICAL ASSOCIATION REGISTRY ON AS
  28. MP53-05 TESTOSTERONE RECOVERY AFTER LONG TIME DEPRIVATION THERAPY: PREDICITIVE FACTORS AND MODELS (NOMOGRAMS)
  29. Testosterone recovery after long time androgen deprivation therapy: The role of duration of deprivation in combination with other predictive factors
  30. Physico – mechanical properties of multi – recycled concrete from precast concrete industry
  31. 4Kscore Test, Prostate Cancer Prevention Trial-Risk Calculator y European Research Screening Prostate-Risk Calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar
  32. Programa de monitorización de la vigilancia activa en cáncer de próstata en España de la Sociedad Española de Urología; resultados preliminares
  33. Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
  34. Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy
  35. 343 Optimizing use of PCA3 in initial prostate biopsy: External validation of a proposed nomogram and proposal for a new system to choose cut-off points in nomograms
  36. Urología y recursos predictivos en la Web
  37. Implementing the use of nomograms by choosing threshold points in predictive models: 2012 updated Partin Tables vs a European predictive nomogram for organ‐confined disease in prostate cancer
  38. Construction of Nomograms for Predicting the Development of Metastases and Biochemical Failure in Cancer of Prostate Treated With Radiation Therapy From Patients of Spanish Cancer Prostate Register (RECAP)
  39. Genetic predisposition to early recurrence in clinically localized prostate cancer
  40. 1468 VALUE OF PERINEURAL INVASION, LYMPHOVASCULAR INVASION AND MULTICENTRICITY IN RADICAL PROSTATECTOMY SPECIMENS AS A PREDICTORS OF BIOCHEMICAL RELAPSE IN ORGAN-CONFINED PROSTATE CANCER
  41. 975 Value of perineural invasion, lymphovascular invasion and multicentricity in radical prostatectomy specimens as a predictors of biochemical relapse in organ-confined prostate cancer
  42. 977 Postoperative nomogram predicting the probability of biochemical recurrence after radical prostatectomy for prostate cancer
  43. A step-by-step algorithm for combining diagnostic tests
  44. Vigencia actual de los nomogramas en la estadificación del cáncer de próstata